JPRN-UMIN000006002已完成未知
Effectiveness of intracoronary bolus abciximab application for patients who suffer from No-Reflow or Slow flow phenomenon during PCI - Effectiveness of intracoronary bolus abciximab application for No-Reflow or Slow flow phenomenon during PCI
Department of Cardiology, Kurashiki Central Hospital0 个研究点目标入组 30 人开始时间: 2011年7月19日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.with hemorrhagic diathesis and/or hypercoagulability 2.under emergent PCI 3.received thrombolytic therapy before PCI 4.more than twice the value of standard CPK and CPK-MB 5.be pregnant or nursing 6.with unprotected LMT disease
研究者
相似试验
Unknown
不适用
Comparison of Intracoronary Versus Intravenous Abciximab in ST-segment Elevation Myocardial Infarction (CICERO)ST-Elevation Myocardial InfarctionNCT00927615University Medical Center Groningen534
已完成
不适用
Intravenous Versus Intracoronary Use of AbciximabIschemic Heart DiseaseAtherosclerosisNCT00685464University Hospital, Gentofte, Copenhagen355
终止
4 期
Intracoronary Bolus Only Compared With Intravenous Bolus and 12-hours Infusion of Abciximab in Non-ST Elevation Myocardial Infarction.AngioplastyMyocardial InfarctionNCT01080638Seoul National University Hospital150
已完成
3 期
Abciximab i.v. Versus i.c. in ST-elevation Myocardial InfarctionST-elevation Myocardial InfarctionNCT00712101University of Leipzig1,912
进行中（未招募）
不适用
Coronary versus Intravenous abCiximab administration during Emergency Reperfusion Of ST-segment elevation myocardial infarction – the CICERO trial - CICEROST-segment elevation myocardial infarction (STEMI)EUCTR2008-004485-12-NLniversity Medical Center of Groningen